Hong Kong Island, Hong Kong, China Delos Capital is the famous VC, which was founded in 2013. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Delos Capital, startups are often financed by ONSET Ventures, New Enterprise Associates, Lumira Ventures. The meaningful sponsors for the fund in investment in the same round are Quadrille Capital, New Enterprise Associates, Lumira Ventures. In the next rounds fund is usually obtained by Square 1 Bank, Questa Capital Management, Quadrille Capital.
We also calculated 8 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight BAROnova, Curamir Therapeutics, OncoMyx Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Medical, Wellness.
The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 42 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Delos Capital works on 16 percentage points less the average amount of lead investments. The important activity for fund was in 2019. The higher amount of exits for fund were in 2016.
| Fund Name | Location |
| Allianz France | France, Ile-de-France, Puteaux |
| Being Group | Japan, Tokyo |
| Comba Telecom Systems Holdings | China, Hong Kong, New Territories |
| Haruyama Holdings | Japan, Okayama, Okayama Prefecture |
| HZTi | China, Hangzhou, Zhejiang |
| Mugar Enterprises | Boston, Massachusetts, United States |
| Oakland County | - |
| SmileGate | Kyonggi-do, Seongnam, South Korea |
| String Ventures | California, San Francisco, United States |
| Tongzhe Investment Management | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Exsilio Therapeutics | $82M | 25 Jun 2024 | Boston, Massachusetts, United States | ||
Ostial Corporation | $7M | 16 Sep 2022 | Campbell, California, United States | ||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
| $10M | 23 Sep 2019 | Woburn, Massachusetts, United States | |||
Antios Therapeutics | $25M | 27 Nov 2018 | Atlanta, Georgia, United States | ||
LipoSeuticals | 29 Jun 2017 | Monmouth Junction, New Jersey, United States | |||
Atia Vision | $3M | 12 May 2015 | California, United States |
– Imperative Care, Inc. announced that it has closed a $260m Series D financing led by D1 Capital Partners.
– New investors HealthCor Investments LLC and Innovatus Capital Partners also joined the round. Existing Imperative Care investors Ally Bridge Group, Bain Capital Life Sciences, Ascension Ventures, Delos Capital, Rock Springs Capital, and Amed Ventures participated in the financing.
– James Rogers from D1 will join Imperative Care’s Board of Directors.
– Proceeds from the financing will be used to support ongoing commercialization and development of a wide range of Imperative Care’s technologies in the broad continuum of stroke care, as well as to create a strategic network of wholly owned development subsidiaries in a number of areas of synergy.
– Antios Therapeutics from San Diego, CA announced the successful completion of a $96m Series B financing.
– The financing was led by Soleus Capital with participation from new major investors RA Capital Management, Adage Capital Management LP, Pontifax and Aisling Capital as well as other healthcare focused funds, Altium Capital, Amzak Health, Granite Point Capital Management, LP, and LifeSci Venture Partners and participation from all of the original Series A investors including Lumira Ventures, CAM Capital, Delos Capital, Domain Associates and Sixty Degree Capital.
– Antios Therapeutics is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Exsilio Therapeutics | $82M | 25 Jun 2024 | Boston, Massachusetts, United States | ||
Ostial Corporation | $7M | 16 Sep 2022 | Campbell, California, United States | ||
Antios Therapeutics | $96M | 12 Apr 2021 | Atlanta, Georgia, United States | ||
| $10M | 23 Sep 2019 | Woburn, Massachusetts, United States | |||
Antios Therapeutics | $25M | 27 Nov 2018 | Atlanta, Georgia, United States | ||
LipoSeuticals | 29 Jun 2017 | Monmouth Junction, New Jersey, United States | |||
Atia Vision | $3M | 12 May 2015 | California, United States |
